Rafferty Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-91,817
| Closed | -$289K | – | 1078 |
|
|
2020
Q3 | $289K | Buy |
91,817
+41,405
| +82% | +$130K | ﹤0.01% | 826 |
|
|
2020
Q2 | $147K | Buy |
+50,412
| New | +$147K | ﹤0.01% | 954 |
|
|
2019
Q3 | – | Sell |
-263,979
| Closed | -$829K | – | 879 |
|
|
2019
Q2 | $829K | Buy |
263,979
+63,858
| +32% | +$201K | 0.01% | 593 |
|
|
2019
Q1 | $744K | Buy |
+200,121
| New | +$744K | 0.01% | 597 |
|